|
EP0873361B1
(en)
|
1995-12-13 |
2006-11-02 |
The Regents Of The University Of California |
Crystals of the ligand-binding domain of the thyroid hormone receptor complexed to a ligand
|
|
US6266622B1
(en)
*
|
1995-12-13 |
2001-07-24 |
Regents Of The University Of California |
Nuclear receptor ligands and ligand binding domains
|
|
US6017958A
(en)
*
|
1996-06-04 |
2000-01-25 |
Octamer, Inc. |
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
|
|
US6217598B1
(en)
*
|
1997-11-25 |
2001-04-17 |
Linvatec Corporation |
End-cutting shaver blade
|
|
EP1598334A1
(en)
*
|
1998-06-30 |
2005-11-23 |
The Regents Of The University Of California |
Thyroid hormone analogues and methods for their preparation
|
|
AR018699A1
(es)
|
1999-06-01 |
2001-11-28 |
Procter & Gamble |
Metodo para el tratamiento de la perdida del cabello el cual comprende administrar una composicion que comprende un compuesto el cual no afecta al corazon
|
|
US6680344B1
(en)
|
1999-06-01 |
2004-01-20 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
US6723717B1
(en)
|
1999-06-01 |
2004-04-20 |
The University Of Texas Southwestern Medical Center |
Sulfur-containing thyroxane derivatives and their use as hair growth promotors
|
|
CA2374263A1
(en)
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylether derivatives
|
|
WO2000072813A1
(en)
*
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
US6516294B1
(en)
|
1999-07-01 |
2003-02-04 |
The Regents Of The University Of California |
Nuclear receptor for 1α,25-dihydroxyvitamin D3 useful for selection of vitamin D3 ligands and a method therefor
|
|
DE10024939A1
(de)
|
2000-05-19 |
2001-11-29 |
Bayer Ag |
Neue Diphenylmethanderivate für Arzneimittel
|
|
GB0015205D0
(en)
|
2000-06-21 |
2000-08-09 |
Karobio Ab |
Bioisosteric thyroid receptor ligands and method
|
|
DE10046029A1
(de)
|
2000-09-18 |
2002-03-28 |
Bayer Ag |
Indazole
|
|
CA2433100A1
(en)
|
2000-12-27 |
2002-07-04 |
Helmut Haning |
Indole derivatives as ligands of thyroid receptors
|
|
US6716877B2
(en)
|
2001-01-31 |
2004-04-06 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method to treat chronic heart failure and/or elevated cholesterol levels
|
|
US6534676B2
(en)
|
2001-01-31 |
2003-03-18 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
|
|
US7504435B2
(en)
|
2001-01-31 |
2009-03-17 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method for stimulating weight loss and/or for lowering triglycerides in patients
|
|
US6777442B2
(en)
|
2001-03-12 |
2004-08-17 |
Bayer Aktiengesellschaft |
Diphenyl derivatives
|
|
US20040253648A1
(en)
*
|
2002-12-10 |
2004-12-16 |
The Regents Of The University Of California |
Method for creating nuclear receptor activity modulating pharmaceuticals
|
|
US7302347B2
(en)
*
|
2002-12-10 |
2007-11-27 |
The Regents Of The University Of California |
Method for creating specific, high affinity nuclear receptor pharmaceuticals
|
|
CA2546601A1
(en)
*
|
2003-11-19 |
2005-06-09 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
|
WO2005085865A2
(en)
*
|
2004-03-09 |
2005-09-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with thyroid hormone receptor beta (thrb)
|
|
US20090232879A1
(en)
|
2005-05-26 |
2009-09-17 |
Metabasis Therapeutics, Inc. |
Thyromimetics for the Treatment of Fatty Liver Diseases
|
|
RU2007148927A
(ru)
*
|
2005-05-26 |
2009-07-10 |
Метабэйзис Терапьютикс, Инк. (Us) |
Новые тиреомиметики, содержащие фосфиновую кислоту
|
|
US20060292194A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Thomas Lavin |
Treatment for burns and adipose deposits using thyroid hormone compound in a human
|
|
KR100965006B1
(ko)
|
2005-07-21 |
2010-06-21 |
에프. 호프만-라 로슈 아게 |
갑상선 호르몬 수용체 작용제로서 피리다진온 유도체
|
|
GB0606212D0
(en)
*
|
2006-03-28 |
2006-05-10 |
Karobio Ab |
Pharmaceutical compositions
|
|
AU2008219585A1
(en)
*
|
2007-02-27 |
2008-09-04 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
|
|
US8076334B2
(en)
|
2007-09-20 |
2011-12-13 |
Hoffmann-La Roche Inc. |
Prodrugs of thyroid hormone analogs
|
|
WO2009089093A1
(en)
*
|
2008-01-04 |
2009-07-16 |
Quatrx Pharmaceuticals Company |
Thyroid hormone receptor agonists
|
|
JP2016517883A
(ja)
|
2013-05-03 |
2016-06-20 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
Ｘ連鎖副腎白質ジストロフィーの処置におけるソベチロムの使用
|
|
JP2018510849A
(ja)
*
|
2015-02-20 |
2018-04-19 |
オレゴン・ヘルス・アンド・サイエンス・ユニバーシティ |
ソベチロムの誘導体
|
|
US11872207B2
(en)
|
2015-12-24 |
2024-01-16 |
Mcmaster University |
Dronedarone and derivatives thereof for treating cancer
|
|
CA3008041C
(en)
|
2015-12-24 |
2024-02-13 |
Mcmaster University |
Compounds for treating cancer
|
|
KR102331596B1
(ko)
|
2016-05-18 |
2021-11-25 |
오레곤 헬스 앤드 사이언스 유니버시티 |
소베티롬의 유도체
|
|
US11325886B2
(en)
|
2016-08-12 |
2022-05-10 |
Oregon Health & Science University |
Amide compounds, pharmaceutical compositions thereof, and methods of using the same
|
|
JP2020500199A
(ja)
|
2016-11-21 |
2020-01-09 |
バイキング・セラピューティクス・インコーポレイテッド |
グリコーゲン蓄積症の治療方法
|
|
AU2018280118B2
(en)
|
2017-06-05 |
2021-07-15 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis
|
|
US11660281B2
(en)
*
|
2017-06-29 |
2023-05-30 |
Yale University |
Compositions and methods of treating or preventing fibrotic lung diseases
|
|
WO2019160980A1
(en)
|
2018-02-14 |
2019-08-22 |
Oregon Health & Science University |
Derivatives of sobetirome
|
|
EA202091979A1
(ru)
|
2018-03-22 |
2021-06-22 |
Вайкинг Терапьютикс, Инк. |
Кристаллические формы и способы получения кристаллических форм соединения
|
|
US12102646B2
(en)
|
2018-12-05 |
2024-10-01 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis and inflammation
|
|
CA3122996A1
(en)
|
2018-12-12 |
2020-06-18 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
EP3931180A1
(en)
|
2019-03-01 |
2022-01-05 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
IT201900006923A1
(it)
*
|
2019-05-16 |
2020-11-16 |
International Soc For Drug Development S R L |
Nuovi tiromimetici con uno scaffold bifenilmetano e loro uso
|
|
KR20220121239A
(ko)
|
2019-11-29 |
2022-08-31 |
아우토반 쎄라퓨틱스, 인크. |
신규한 갑상선 호르몬 모방제
|
|
CN111116684B
(zh)
*
|
2019-12-31 |
2020-09-25 |
厦门甘宝利生物医药有限公司 |
一种具有甲状腺激素受体激动剂特性的肝靶向化合物及其药物组合物
|
|
JP2023530708A
(ja)
*
|
2020-06-17 |
2023-07-19 |
オートバーン セラピューティクス，インク． |
甲状腺様作用剤
|
|
US20230242473A1
(en)
*
|
2020-06-17 |
2023-08-03 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|